EDWARD VILLARREAL: Open Payments
NPI 1215438072 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 25 payments from 17 companies in 2025. Trend: 2023 $51 · 2024 $968 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $241 |
| Boston Scientific Corporation | 1 | $143 |
| Novo Nordisk Inc | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| KYOWA KIRIN, INC. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Amarin Pharma, Inc. | 1 | $113 |
| ABIOMED | 1 | $106 |
| CVRx, Inc. | 1 | $89 |
| Lilly USA, LLC | 3 | $49 |
Products named: Kerendia, AMS 700, Auvelity, CRYSVITA, AUSTEDO XR, Vascepa, Barostim Neo System, SAPIEN 3 Ultra RESILIA.
Industry payments across TX — which companies pay providers there.
